Acute Coronary Syndromes
Conference Coverage
Poor control of serum urate linked to cardiovascular risk in patients with gout
A new study of medical records adds to the evidence linking gout, particularly in patients with poorly controlled serum urate level, to...
Conference Coverage
Early estrogen loss increases cardiovascular risk in women
Clinicians should especially be aware of functional hypothalamic amenorrhea as a condition that could increase women’s risk of cardiovascular...
From the Journals
Diabetes becoming less potent risk factor for CVD events
Diabetes is no longer equal to cardiovascular disease as a risk factor for cardiovascular events, according to a population-based study in Ontario...
From the Journals
New deep dive into Paxlovid interactions with CVD meds
The review tackles potential drug-drug interactions with the antiviral drug and today’s most commonly prescribed cardiovascular drugs.
From the Journals
Cardiac biomarkers track with hormone therapy in transgender people
A pilot study spotlights differences in two common biomarkers of cardiac disease as well as the need for greater inclusivity in cardiovascular...
From the Journals
SPRINT’s intensive therapy benefit fades once BP creeps back up
Despite an all-cause mortality benefit from intensive therapy in SPRINT, benefit was lost after the trial.
From the Journals
ACC issues guidance on ED evaluation of acute chest pain
A major challenge is to quickly identify the small number of patients with acute coronary syndrome (ACS).
Commentary
Like texting and driving: The human cost of AI
Enthusiastic presentations on the use of AI in medicine at a recent conference left this cardiologist concerned about the potential loss of human...
From the Journals
Newer drugs not cost effective for first-line diabetes therapy
Costs of SGLT2 inhibitors and GLP-1 receptor agonists ‘need to be lowered substantially’ to improve health outcomes and prevent health disparities...
From the Journals
SMART-CHOICE 3-year results support dropping aspirin after PCI
The antiplatelet strategy after PCI is currently shifting to reduce the duration of DAPT.
Commentary
The winding road that leads to optimal temperature management after cardiac arrest
Today’s life-saving intervention proves harmful tomorrow, but withholding it may constitute malpractice a few months down the road.